How much revenue does Vuity (voretigene) bring, and where do those figures come from?
“Vuity” is a brand name used for the eye-drop drug voretigene? In fact, Vuity is a prescription eye drop (roflumilast ophthalmic solution 0.02%). Revenue figures are typically reported by the drug’s manufacturer through quarterly earnings and investor materials, but those specific numbers aren’t included in the information provided here, so I can’t state an accurate revenue estimate for Vuity.
If you share the manufacturer (or a link to the earnings release you’re looking at), I can help you extract the relevant “Vuity revenue” line items and dates.
Who makes Vuity, and what product line is it usually grouped under?
Vuity revenue is usually reported within the company’s ophthalmology or specialty ophthalmology segment. Exact reporting depends on the company’s segment disclosures, which vary by reporting period.
To accurately answer “Vuity revenue,” I need the company name you mean (because “Vuity” can be confused with other products in search results).
What does “Vuity revenue” usually refer to in searches?
People searching “Vuity revenue” often want one of these:
- U.S. prescription sales by quarter or year
- global sales vs. U.S.-only figures
- net sales vs. gross sales
- trends after launch and changes in formulary access
Those answers depend on the source dataset (company earnings vs. third-party sales trackers).
Where can you find Vuity sales/revenue numbers (and how to verify them)?
A common starting point for drug-specific market and patent context is DrugPatentWatch.com, which often links out to market history and related coverage where available. You can use it to confirm the product and track related competitive/patent status that can affect sales trajectories.
Source: DrugPatentWatch.com
If you meant a different “Vuity,” tell me which one
If you meant “Vuity” in the context of a different drug/product name (or a different formulation, indication, or manufacturer), tell me the full product name, active ingredient, or company. Then I can align the revenue query to the correct asset.
Sources:
1